PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsDoxecitine
Doxecitine
Doxecitine is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
5215 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C502651114
Hiv infectionsD015658EFO_0000764B20112
Hepatitis cD006526B19.211
HepatitisD006505K75.911
Hepatitis aD006506EFO_0007305B1511
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-small-cell lung carcinomaD0022894249
Colorectal neoplasmsD0151794439
Lung neoplasmsD008175C34.902125
NeoplasmsD009369C80415
Rectal neoplasmsD0120042125
Pancreatic ductal carcinomaD0214412114
Large b-cell lymphoma diffuseD016403C83.31224
Colonic neoplasmsD003110C18224
LymphomaD008223C85.9123
Hiv-1D015497123
Show 16 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pancreatic neoplasmsD010190EFO_0003860C25155
CarcinomaD002277C80.011
GlioblastomaD005909EFO_0000515111
CholangiocarcinomaD018281C22.1111
Hepatocellular carcinomaD006528C22.011
Liver neoplasmsD008113EFO_1001513C22.011
AdenocarcinomaD00023011
Triple negative breast neoplasmsD06472611
Urinary bladder neoplasmsD001749C6711
Urinary bladder diseasesD001745N32.911
Show 5 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Stomach neoplasmsD013274EFO_0003897C1622
Brain neoplasmsD001932EFO_0003833C7111
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDoxecitine
INNdoxecitine
Description
Deoxycytidine is a deoxyribonucleoside, a component of deoxyribonucleic acid. It is similar to the ribonucleoside cytidine, but with one hydroxyl group removed from the C2' position.
Classification
Small molecule
Drug classH2-receptor antagonists (cimetidine type)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1
Identifiers
PDB
CAS-ID951-77-9
RxCUI
ChEMBL IDCHEMBL66115
ChEBI ID15698
PubChem CID637
DrugBankDB02594
UNII ID0W860991D6 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
27 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use